by palligoelme@gmail.com | Sep 18, 2026 | Clinical Trials
Conditions: Nocturia; Nocturnal Urinary Incontinence Interventions: Drug: TolterodineTartrate ER; Drug: Mirabegron; Drug: Placebo Sponsors: University of California, San Francisco; National Institute on Aging (NIA) Recruiting Conditions: Nocturia; Nocturnal Urinary...
by palligoelme@gmail.com | Sep 18, 2026 | Clinical Trials
Conditions: Pancreatic Cancer Interventions: Drug: Cisplatin; Drug: Albumin-bound Paclitaxel (Ⅱ); Drug: Albumin-bound Paclitaxel (Ⅱ); Drug: Capecitabine; Drug: Capecitabine; Drug: Gemcitabine; Drug: Gemcitabine Sponsors: Tianjin Medical University Cancer Institute...
by palligoelme@gmail.com | Sep 18, 2026 | Clinical Trials
Conditions: Chronic Pain; Veterans Interventions: Other: Self-Guided Digital Acceptance and Commitment Therapy Program Sponsors: University Health Network, Toronto; Chronic Pain Centre of Excellence for Canadian Veterans Recruiting Conditions: Chronic Pain; Veterans...
by palligoelme@gmail.com | Sep 18, 2026 | Clinical Trials
Conditions: CASA Intervention; Usual Care Interventions: Behavioral: The Caregivers-Patients Support to Cope with Advanced Cancer (CASA) is a five-session, manualized, meaning-centered psychotherapy developed for Puerto Rican patients and caregivers coping with...
by palligoelme@gmail.com | Sep 18, 2026 | Clinical Trials
Conditions: Bite Force; Masseter Muscle; Zirconia Crowns; Primary Molars Interventions: Procedure: Preformed Bioflx Crown; Procedure: Preformed Zirconia Crown Sponsors: Tanta University Not yet recruiting Conditions: Bite Force; Masseter Muscle; Zirconia Crowns;...
by palligoelme@gmail.com | Sep 18, 2026 | Clinical Trials
Conditions: Acute Myeloid Leukemia (AML) Interventions: Drug: Liposome Mitoxantrone; Drug: Venetoclax; Drug: Azacitidine Sponsors: Institute of Hematology & Blood Diseases Hospital, China Not yet recruiting Conditions: Acute Myeloid Leukemia (AML) Interventions:...